Amicus Therapeutics Stock Statistic Functions Beta

FOLD Stock  USD 9.66  0.16  1.68%   
Amicus Therapeutics statistic functions tool provides the execution environment for running the Beta function and other technical functions against Amicus Therapeutics. Amicus Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of statistic functions indicators. As with most other technical indicators, the Beta function function is designed to identify and follow existing trends. Amicus Therapeutics statistical functions help analysts to determine different price movement patterns based on how price series statistical indicators change over time. Please specify Time Period to run this model.

The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Amicus Therapeutics correlated with the market. If Beta is less than 0 Amicus Therapeutics generally moves in the opposite direction as compared to the market. If Amicus Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Amicus Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Amicus Therapeutics is generally in the same direction as the market. If Beta > 1 Amicus Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Amicus Therapeutics Technical Analysis Modules

Most technical analysis of Amicus Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Amicus from various momentum indicators to cycle indicators. When you analyze Amicus charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Amicus Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Amicus Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Amicus Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Amicus Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Amicus Therapeutics's daily price indicators and compare them against related drivers, such as statistic functions and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Amicus Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Amicus Therapeutics, we also check how macroeconomic factors affect Amicus Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Payables Turnover1.62.52.472.85
Days Of Inventory On Hand284.01225.21583.75486.23
Hype
Prediction
LowEstimatedHigh
7.059.5912.13
Details
Intrinsic
Valuation
LowRealHigh
9.1711.7114.25
Details
Naive
Forecast
LowNextHigh
6.939.4712.01
Details
13 Analysts
Consensus
LowTargetHigh
15.7717.3319.24
Details

Learn to be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Alpha Finder Now

   

Alpha Finder

Use alpha and beta coefficients to find investment opportunities after accounting for the risk
All  Next Launch Module

Amicus Therapeutics pair trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amicus Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amicus Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Amicus Therapeutics Pair Trading

Amicus Therapeutics Pair Trading Analysis

The ability to find closely correlated positions to Amicus Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amicus Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amicus Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amicus Therapeutics to buy it.
The correlation of Amicus Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amicus Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amicus Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amicus Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Amicus Therapeutics is a strong investment it is important to analyze Amicus Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Amicus Therapeutics' future performance. For an informed investment choice regarding Amicus Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Amicus Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For information on how to trade Amicus Stock refer to our How to Trade Amicus Stock guide.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amicus Therapeutics. If investors know Amicus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amicus Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.34)
Revenue Per Share
1.629
Quarterly Revenue Growth
0.367
Return On Assets
0.0116
Return On Equity
(0.67)
The market value of Amicus Therapeutics is measured differently than its book value, which is the value of Amicus that is recorded on the company's balance sheet. Investors also form their own opinion of Amicus Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Amicus Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amicus Therapeutics' market value can be influenced by many factors that don't directly affect Amicus Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amicus Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amicus Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amicus Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.